drugset / Trial / NCT03678480
A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Randomized, double-blind, active-controlled, parallel-group study of HTD1801 in adolescents.
Timeline
- Start
- 2021-03-01
- Primary completion
- 2021-10-04
- Completion
- 2021-11-04
Outcome
Outcome not reported
Stopped: “Corporate decision”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ursodeoxycholic Acid | Small molecule | 250 mg | — |
| Subject | berberine ursodeoxycholate | Small molecule | 500 mg | — |